En savoir plus

The ISIDORe consortium has launched its first call to support research on SARS-CoV-2 and Monkeypox virus earlier this summer. It provides free of charge access to more than 300 services from ISIDORe’s integrated portfolio of cutting-edge research services dedicated to epidemic-prone disease research.

It will follow in coming weeks with a new access call dedicated to:

• RG4 Pathogens
• Respiratory pathogens (excluding SARS-CoV-2)
• Vector-borne pathogens and their vectors
• Other pathogens with epidemic potential (including Disease X)

The ISIDORe coordination team is pleased to launch the second information webinar to provide you with information about the access calls and application modalities, as well as to answer your questions.

Participation in the event is free, but registration is required.